Friday, July 29, 2011 5:00:14 PM
You see the stock was not trading anywhere near true value. the stock was being naked shorted to death by (many possibilities) ie a large biotech.
the offering lowered the float so low that the stock cannot be manipulated daily. It was really a stroke of genius and the first ive seen done successfully in my 8 years of trading!
also if they were to release the warrants now, people would just dump them onto the market and we may be right back to square one with heavy shorting again by the powers that be.
Wall street never plays fair any more.
Recent NEPH News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:05:23 PM
- Nephros Announces Financial Results for Quarter Ended June 30, 2024 • GlobeNewswire Inc. • 08/08/2024 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:00:33 PM
- Nephros Schedules Second Quarter 2024 Financial Results Conference Call • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/17/2024 09:18:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:05:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/24/2024 04:15:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:49:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:26:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:25:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 08:23:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:16:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:40:58 PM
- Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 03/07/2024 09:15:00 PM
- Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:48:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:17:43 PM
- Nephros Announces Results for Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/08/2023 09:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:30:14 PM
- Nephros Hires Judy Krandel as Chief Financial Officer • GlobeNewswire Inc. • 11/01/2023 11:30:00 AM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM